SUBMISSION OF SDD COMPLIANCE CERTIFICATE UNDER REGULATION 3(5)AND 3(6) OF SEBI (PROHIBITION OF INSIDER TRADING) REGULATION 2015 OF THE QUARTER ENDED DECEMBER 31 2024.
Submission Of SDD Compliance Certificate Under Regulation 3(5) And 3(6) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations, 2015 For The Quarter Ended December 31St, 2024.
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Welcure Drugs and Pharmaceuticals Ltd. on 6ix
Earlier from Welcure Drugs and Pharmaceuticals
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Jan 10 2025
- Statement Of Investor Grievances Under Regulation 13(3) Of SEBI (Listing Obligation And Disclosure Requirement) Regulation, 2015.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Dec 27 2024
- Closure of Trading Window
Later from Welcure Drugs and Pharmaceuticals
- Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs & Pharmaceuticals Limited Held On Today I.E. Wednesday, 22Nd January, 2025
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Jan 22 2025
- Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Jan 23 2025
- Board Meeting Intimation for Intimation Of Meeting Of BOD Under Regulation 29 Of The SEBI(LODR) Regulation 2015.
Follow Welcure Drugs and Pharmaceuticals into a list and get an email when it puts out news.
Follow Welcure Drugs and Pharmaceuticals